Cargando…

Hydroxychloroquine: Corrected QT interval prolongation, first degree atrioventricular block and left bundle branch block during an off-label treatment with hydroxychloroquine for COVID-19 pneumonia: 3 case reports

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334118/ http://dx.doi.org/10.1007/s40278-020-80364-9

Ejemplares similares

Azithromycin/hydroxychloroquine: Lengthening of the QT interval, bradycardia and atrioventricular block following an off-label use: case report
Publicado: (2020)

Hydroxychloroquine: Right bundle branch block and QTc prolongation following off label use: case report
Publicado: (2020)

Hydroxychloroquine/lopinavir/ritonavir: Second-degree atrioventricular block (Mobitz II) with left bundle branch block and paroxysmal atrial fibrillation with bradycardia following off label use: case report
Publicado: (2022)

Azithromycin/hydroxychloroquine/lopinavir/ritonavir: Complete atrioventricular-block, torsades-de-pointes and QT-interval-prolongation following off label use: 2 case reports
Publicado: (2020)

Hydroxychloroquine: Prolonged QT interval following off label use: case report
Publicado: (2020)

Hydroxychloroquine: QT interval prolongation following off-label use: case report
Publicado: (2022)

Hydroxychloroquine-associated QT interval prolongation
Publicado: (2020)

Azithromycin/hydroxychloroquine: Prolonged QT interval during off label use: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine interaction: QT interval prolongation following off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: Corrected QT-interval prolongation following off label use: case report
Publicado: (2020)

Hydroxychloroquine: Electrical storm and QT interval prolongation following off-label use: case report
Publicado: (2020)

QT interval prolongation with hydroxychloroquine plus azithromycin
Publicado: (2020)

Assessment of QT and JT Intervals in Patients With Left Bundle Branch Block
por: Tabatabaei, Peyman, et al.
Publicado: (2016)

Hydroxychloroquine: QT prolongation due to off-label use: case report
Publicado: (2022)

Azithromycin/hydroxychloroquine: Prolongation of the QT interval: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: QT prolongation following off label use: case report
Publicado: (2022)

Azithromycin/hydroxychloroquine: Prolonged corrected QT following off label use: case report.
Publicado: (2020)

Effects of hydroxychloroquine treatment on QT interval
por: Hooks, Matthew, et al.
Publicado: (2020)

Hydroxychloroquine: Prolonged QTc interval following off-label use: case report
Publicado: (2020)

Hydroxychloroquine: QTc interval prolonged following off label use: case report
Publicado: (2021)

Hydroxychloroquine/remdesivir/tocilizumab: Increase in corrected QT interval and off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: QT-interval prolongation and polymorphic ventricular tachycardia arrest due to off-label use: 2 case reports
Publicado: (2021)

Azithromycin/hydroxychloroquine: QT prolongation and ventricular extrasystole secondary to off label use: case report
Publicado: (2021)

Treatment of atrial fibrillation with third-degree atrioventricular block by pacing His bundle and left bundle branch: Case report
por: Zhang, Denghong, et al.
Publicado: (2020)

System biological investigations of hydroxychloroquine and azithromycin targets and their implications in QT interval prolongation
por: Khan, Abdul Arif, et al.
Publicado: (2020)

Prolongation of QT interval due to hydroxychloroquine overdose used in COVID-19 treatment
por: Aksel, Gökhan, et al.
Publicado: (2020)

Hydroxychloroquine: Borderline prolongation of QTc interval during off-label treatment: case report
Publicado: (2020)

Ceftriaxone/hydroxychloroquine/tocilizumab: QT prolongation, torsade-de-pointes and off label use: case report
Publicado: (2020)

An antiarrhythmic approach to hydroxychloroquine-induced QT prolongation
por: Yetkin, E., et al.
Publicado: (2020)

Hydroxychloroquine: risk of QT prolongation and drug interactions
Publicado: (2020)

Azithromycin/hydroxychloroquine: Torsade de pointes, premature atrial contraction and right bundle branch block following off-label use: 4 case reports
Publicado: (2021)

Off-label use of chloroquine, hydroxychloroquine, azithromycin and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel
por: Zequn, Zheng, et al.
Publicado: (2021)

Prolonged QT Interval in a Patient With Coronavirus Disease-2019: Beyond Hydroxychloroquine and Azithromycin
por: Anupama, B K, et al.
Publicado: (2020)

Atrioventricular block at the distal His bundle: Electrophysiological insights from left bundle branch pacing
por: Vijayaraman, Pugazhendhi, et al.
Publicado: (2019)

Azithromycin/hydroxychloroquine: QT prolongation with a notched broad T-wave following off-label therapy: case report
Publicado: (2020)

HYDROXYCHLOROQUINE ATTENUATES HERG CHANNEL BY PROMOTING THE MEMBRANE CHANNEL DEGRADATION: EVIDENCES FOR QT-INTERVAL PROLONGATION IN COVID-19 PATIENTS WITH HYDROXYCHLOROQUINE TREATMENT
por: Wang, Xiqiang, et al.
Publicado: (2022)

Left Bundle Pacing for Left Bundle Branch Block and Intermittent Third-Degree Atrioventricular Block in a MYH7 Mutation-Related Hypertrophic Cardiomyopathy With Restrictive Phenotype in a Child
por: Zhang, Luyan, et al.
Publicado: (2020)

Azithromycin/favipiravir/hydroxychloroquine interactions: Corrected QT (QTc) interval prolongation due to pharmacodynamic interaction following off label use: 2 case reports
Publicado: (2021)

Hydroxychloroquine and QT prolongation: reassuring data in approved indications
por: Pareek, Anil, et al.
Publicado: (2020)

Left ventricular septal pacing versus left bundle branch pacing in the treatment of atrioventricular block
por: Zhou, Yu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hhcgv3qi7ovpg1v7urvfv6tojs